T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections
Top Cited Papers
- 30 June 2009
- journal article
- review article
- Published by Elsevier BV in Antiviral Research
- Vol. 82 (3), 95-102
- https://doi.org/10.1016/j.antiviral.2009.02.198
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Efficacy of orally administered T-705 pyrazine analog on lethal West Nile virus infection in rodentsAntiviral Research, 2008
- Highly pathogenic RNA viral infections: Challenges for antiviral researchAntiviral Research, 2008
- Update on Avian Influenza A (H5N1) Virus Infection in HumansThe New England Journal of Medicine, 2008
- The Anti-Yellow Fever Virus Activity of Ribavirin Is Independent of Error-Prone ReplicationMolecular Pharmacology, 2006
- Vaccines: past, present and futureNature Medicine, 2005
- Mechanism of Action of T-705 against Influenza VirusAntimicrobial Agents and Chemotherapy, 2005
- Foot-and-Mouth DiseaseClinical Microbiology Reviews, 2004
- Treatment of Bolivian Hemorrhagic Fever with Intravenous RibavirinClinical Infectious Diseases, 1997
- Antiviral treatment of argentine hemorrhagic feverAntiviral Research, 1994
- Synthesis and antiviral activity of some phosphates of the broad-spectrum antiviral nucleoside, 1-.beta.-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin)Journal of Medicinal Chemistry, 1978